Pfizer Inc (PFE)

PFE (NYSE:Drugs) EQUITY
$36.06
pos +0.33
+0.92%
Today's Range: 35.87 - 36.46 | PFE Avg Daily Volume: 22,445,400
Last Update: 07/31/15 - 4:03 PM EDT
Volume: 28,796,134
YTD Performance: 14.70%
Open: $35.92
Previous Close: $35.73
52 Week Range: $27.51 - $36.13
Oustanding Shares: 6,157,669,933
Market Cap: 220,198,276,804
6-Month Chart
TheStreet Ratings Grade for PFE
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 8 8 7 7
Moderate Buy 0 0 0 0
Hold 4 4 4 4
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 1
Mean Rec. 1.92 1.92 2.00 2.00
Latest Dividend: 0.28
Latest Dividend Yield: 3.13%
Dividend Ex-Date: 08/05/15
Price Earnings Ratio: 26.89
Price Earnings Comparisons:
PFE Sector Avg. S&P 500
26.89 25.40 25.96
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
5.30% 22.11% 50.70%
GROWTH 12 Mo 3 Yr CAGR
Revenue -3.80 -0.26 -0.10
Net Income -58.50 0.04 0.01
EPS -55.50 0.13 0.04
Earnings for PFE:
EBITDA 19.04B
Revenue 49.61B
Average Earnings Estimates
Qtr (09/15) Qtr (12/15) FY (12/15) FY (12/16)
Average Estimate $0.51 $0.50 $2.05 $2.31
Number of Analysts 7 7 11 12
High Estimate $0.53 $0.52 $2.06 $2.66
Low Estimate $0.49 $0.47 $2.04 $2.15
Prior Year $0.57 $0.54 $2.26 $2.05
Growth Rate (Year over Year) -10.78% -8.20% -9.17% 12.66%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
By

David Katz

 | Jul 30, 2015 | 11:00 AM EDT

Drugmaker has one of the best showings of earnings season.

By

David Katz

 | Jul 30, 2015 | 8:30 AM EDT

Drugmaker has one of the best showings of earnings season.

By

Timothy Collins

 | Jul 29, 2015 | 10:55 AM EDT

PFE now has a very large bull flag with the potential to push the shares higher.

By

Jim Cramer

 | Jul 16, 2015 | 2:51 PM EDT

They should learn to trust techs, financials.

By

Dick Arms

 | Jul 16, 2015 | 7:00 AM EDT

If you went long last week, take profits, but don't go short just yet.

By

Jim Cramer

 | Jul 15, 2015 | 7:07 AM EDT

These stocks will be up so high today, that many fans will say "no thanks."

By

Roger Arnold

 | Jun 25, 2015 | 1:46 PM EDT

As health-care stocks rally, it's time for politicians to move on.

By

Jim Cramer

 | Jun 11, 2015 | 2:18 PM EDT

New companies are coming up with major drugs.

By

Jim Cramer

 | Jun 4, 2015 | 6:36 AM EDT

The dollar is weakening. That's actually good for stocks. 

By

Bryan Ashenberg

 | May 29, 2015 | 7:31 AM EDT

The revised GDP figure could impact trading.

$51 billion - How much Uber is valued at in its last financing round. The unicorns keep g...
....put protection is cheap! Seems every time we come down to this 12 or 11 level in VIX ...
Chevron (CVX) and the weak weekly chart, or is it?    Why would anyone want to...

Care to comment on my prior post?

REAL MONEY PRO'S BEST IDEAS

News Breaks

Powered by

Columnist Tweets

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.